Conference Programme

Tentative Conference Agenda

Explore the proposed two-day programme developed around the conference Session Tracks and aligned United Nations Sustainable Development Goals.

Conference Format Hybrid Conference In-person and virtual participation
Programme 2 Days 27–28 May 2027
Academic Scope 11 Tracks Conference Session Tracks
Research Scope 20 Areas Call for Papers themes
SDG Alignment 3 SDGs SDGs 3, 4 and 9
Tentative Agenda & Timings

Session timings, sequence, track grouping and allocations are tentative and subject to change. Final timings will be confirmed closer to the conference. All timings follow the local time of the conference location.

Day 01

Opening, Keynote & Technical Sessions

27 MAY 2027 HYBRID
  1. 09:00 AM 09:30 AM

    Registration, Welcome Kit Collection & Virtual Check-in

    Participant arrival, credential verification and virtual lobby access.

    HYBRID
  2. 09:30 AM 09:45 AM

    Networking Tea & Digital Welcome

    Informal networking for on-site and virtual participants.

    HYBRID
  3. 09:45 AM 10:30 AM

    Welcome Address, Opening Plenary & Keynote Presentation I

    Opening of the conference and introduction to its research focus.

    PLENARY
  4. 10:30 AM 12:30 PM

    Concurrent Technical Session I

    3 TRACKS
    Track 01
    Innovations in Antimicrobial Drug Discovery
    34
    Track Overview

    This track focuses on the latest advancements in the discovery of antimicrobial agents. It will explore novel compounds, mechanisms of action, and the potential for overcoming resistance.

    Track 02
    Molecular Diagnostics in Microbial Pathogenesis
    34
    Track Overview

    This session will delve into cutting-edge molecular diagnostic techniques for identifying microbial pathogens. Emphasis will be placed on their application in clinical settings and their role in improving patient outcomes.

    Track 03
    Translational Research in Microbial Therapeutics
    39
    Track Overview

    This track aims to bridge the gap between laboratory research and clinical application of microbial therapeutics. Discussions will include successful case studies and challenges faced in translational research.

  5. 12:30 PM 01:30 PM

    Lunch & Networking Break

    Refreshment interval and networking opportunity.

    BREAK
  6. 01:30 PM 03:30 PM

    Concurrent Technical Session II

    3 TRACKS
    Track 04
    Clinical Research on Antimicrobial Resistance
    34
    Track Overview

    This session will address the growing challenge of antimicrobial resistance in clinical settings. Researchers will present findings on resistance mechanisms and strategies for effective management.

    Track 05
    Laboratory Techniques in Microbial Drug Development
    39
    Track Overview

    This track will highlight innovative laboratory techniques used in the development of microbial drugs. Participants will discuss methodologies that enhance the efficiency and effectiveness of drug discovery.

    Track 06
    Pathogen-Host Interactions: Implications for Therapy
    34
    Track Overview

    This session will explore the complex interactions between pathogens and their hosts. Understanding these dynamics is crucial for developing targeted therapeutic strategies.

  7. 03:30 PM 04:00 PM

    Interactive Q&A, Day 1 Summary & Group Photo

    Closing interaction and key takeaways from the first day.

    CLOSING
Day 02

Keynote, Technical Sessions & Awards

28 MAY 2027 HYBRID
  1. 09:00 AM 09:15 AM

    Participant Check-in & Day 2 Welcome

    On-site attendance confirmation and virtual lobby access.

    HYBRID
  2. 09:15 AM 10:00 AM

    Keynote Presentation II

    Expert address on the future of the conference research domain.

    PLENARY
  3. 10:00 AM 12:00 PM

    Concurrent Technical Session III

    3 TRACKS
    Track 07
    Therapeutic Innovations in Microbial Infections
    34
    Track Overview

    This track will showcase novel therapeutic approaches for treating microbial infections. Emphasis will be placed on innovative strategies that address current limitations in treatment.

    Track 08
    Biotechnology Applications in Microbial Drug Discovery
    39
    Track Overview

    This session will focus on the role of biotechnology in enhancing microbial drug discovery processes. Participants will discuss biotechnological advancements that facilitate the identification and development of new therapeutics.

    Track 09
    Emerging Trends in Microbial Therapeutics
    39
    Track Overview

    This track will examine emerging trends and future directions in microbial therapeutics. Discussions will include the impact of new technologies and research findings on therapeutic development.

  4. 12:00 PM 01:00 PM

    Lunch & Networking Break

    Refreshment interval and professional networking.

    BREAK
  5. 01:00 PM 03:00 PM

    Concurrent Technical Session IV

    2 TRACKS
    Track 10
    Regulatory Challenges in Microbial Drug Development
    34
    Track Overview

    This session will address the regulatory landscape surrounding microbial drug development. Experts will discuss the challenges and opportunities in navigating regulatory pathways for new therapeutics.

    Track 11
    Global Perspectives on Microbial Drug Resistance
    34
    Track Overview

    This track will provide a global overview of microbial drug resistance and its implications for public health. Participants will share insights on international efforts to combat resistance and promote effective therapies.

  6. 03:00 PM 03:30 PM

    Publications, Best Paper & Best Presentation Awards

    Publication guidance and recognition of outstanding research contributions.

    AWARDS
  7. 03:30 PM 04:00 PM

    Valedictory Session, Closing Remarks & Group Photo

    Conference summary, acknowledgements and formal conclusion.

    CLOSING
Aligned SDGs
3 Good Health and Well-being 4 Quality Education 9 Industry, Innovation and Infrastructure

Be Part of ICMDDT-27

Submit your research or complete your conference registration.